USPSTF States That Evidence is Insufficient to Recommend Visual Skin Cancer Screenings

Share this content:
It is unclear whether clinician skin cancer screenings are more beneficial or harmful to people in the United States.
It is unclear whether clinician skin cancer screenings are more beneficial or harmful to people in the United States.

It is unclear whether clinician skin cancer screenings are more beneficial or harmful to people in the United States, according to an article recently published in JAMA.1

Cancers of the skin, including basal cell carcinoma and melanoma, are common in the U.S., though they are often treatable. The United States Prevention Services Task Force (USPSTF) commissioned an evidence review to determine the effectiveness of skin cancer screenings, including reductions of mortality and morbidity, as well as any potential harms.

The review found, however, that evidence was limited, both for effectiveness of screening for the reduction of morbidity and mortality in cases of melanoma, as well as for potential harm.

The authors write that the potential for harm exists, even if it is difficult to document. One of 23 participants in a reviewed study, for example, underwent an excision for a non-cancerous lesion.

RELATED: Water Contaminated With Arsenic Linked to Skin Cancer

The USPSTF recommendations update those given in 2009, though it is states that current evidence is insufficient to recommend clinical visual skin examinations. A statement about patient self-examinations was not included.

Reference

  1. US Preventive Services Task Force. Screening for skin cancer: US preventive services task force recommendation statement. JAMA. 26 Jul 2016. doi:10.1001/jama.2016.8465 [Epub ahead of print]

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters